Cyber Defense

Overview
When it comes to cyber defense, having a well-rounded toolbox of strategies is important. For this milestone paper draft, you will be
analyzing trends in personnel or human factors, data protection, and system protection. You will evaluate these trends as solutions
using threat modeling, a skill you practiced in Modules Three and Four. This draft is an opportunity to begin work on your final
project and receive feedback from your instructor before completing your project in Module Seven.
Scenario
For this final project, put yourself in the role of a security analyst who is performing an audit of your company. Your organization is a
mid-sized manufacturing company that released its own smart headset. The headset has the ability to project important documents
on an optical screen for the technicians in the field. The documents could be product schematics, invoices, emails, text messages, or
any documents put in the shared drive on the server. The headset has constant communication with the server that resides in the
central office; the connection is made through the technicians’ cell phones via the Bluetooth connection.
Prompt
Create your cyber defense paper draft by selecting your trends below and completing a threat model for each trend using what you
learned in Stepping Stone One. Be sure to integrate your feedback on this assignment into your final, polished project submission in
Module Seven.
You must address the critical elements listed below.
I. Personnel or human factor trend
Select a personnel or human factor trend and discuss the following critical elements:
A. Describe how the trend or strategy provides protection to an organization.
B. Defend the trend as a credible solution based on your analysis of the threat model for the scenario.

Select a data protection strategy or technology and discuss the following critical elements:
A. Describe how the strategy or technology provides protection to an organization.
B. Defend the strategy or technology as a credible solution based on your analysis of the threat model for the
scenario.
III. System protection trend
Select a technology in one of the following areas:
● Network protection technologies
● Endpoint/server protection technologies
● Software code protection strategies and technologies
For your selected technology, discuss the following critical elements:
A. Describe how the selected technology provides protection to an organization.
B. Defend the technology as a credible solution based on your analysis of the threat model for the scenario.

 

Sample Solution

This review provides an overview of pharmacogenetics generally and of current knowledge on pharmacogenetic factors that are connected with both the host and the target (i.e., the infection), which may represent intra-and interindividual variability in responsiveness to antiretroviral treatment. Specifically, this article looks to provide a superior understanding of processes identified with HIV drug-resistant variations and to antiretroviral metabolism and transport. A better understanding of these processes is significant to deciding optimal pharmacotherapy for HIV patients.

2. PERSONALIZED MEDICINE AND GENOMICS

The idea of “personalized medicine” was expected in the late 1800s by the Canadian Physician Sir William Osler who noticed “the colossal variability among individuals”(Issa, 2007); be that as it may, the more advanced definition has developed to consolidate individual genomic data into a patient’s clinical assessment and family history to guide medicinal administration. Major ranges of applied research in this field include recognizing the genetic basis of basic ailments, studying how the environment and genes act together to give rise to human diseases, and utilizing pharmacogenetic biomarkers to encourage more compelling medication treatment. In spite of understanding the genetic commitment to human diseases is a long way from complete, many “normal” DNA variations have been connected with diseases and phenotypic traits, and Direct-To-Consumer (DTC) organizations have misused this data to offer DNA-based testing that gives knowledge into individual traits and disease risks. Interestingly, when thought about against each other, diverse risk figuring strategies and decisions of genetic markers have brought about discrepant results between DTC companies (Ng et al., 2009). Thus, practice recommendations have been made to the DTC organizations, which incorporated a strong support to fuse the same number of enlightening pharmacogenetic markers as possible, (Ng et al., 2009) which most DTC organizations now do.

Pharmacogenetics has ended up one of the main and conceivably most actionable regions of the personalized medication paradigm, as confirm by the expanded accessibility of clinical ph

This question has been answered.

Get Answer
WeCreativez WhatsApp Support
Our customer support team is here to answer your questions. Ask us anything!
👋 Hi, Welcome to Compliant Papers.